The Potential of Topical Phytopharmaceuticals for the Management of COVID-19-Associated Cough from the Perspective of Traditional Persian Medicine
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into the most severe pandemic affecting millions of people worldwide.
Main Authors: | Parmis Badr, Fatemeh Etemadpour, Reyhaneh Chini, Nikoo Khalili Moghadam |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2022-07-01
|
Series: | Iranian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://ijms.sums.ac.ir/article_48459_6b46d091404c30dd078e5cb77770260a.pdf |
Similar Items
-
Traditional and Recent Evidence on Five Phytopharmaceuticals from Rosa damascena Herrm.
by: Forough Afsari Sardari, et al.
Published: (2019-07-01) -
Patterns of Cough Medication Prescribing among Patients with Chronic Cough in Florida: 2012–2021
by: Seonkyeong Yang, et al.
Published: (2023-09-01) -
Evaluation of Cough Medication Use Patterns in Ambulatory Care Settings in the United States: 2003–2018
by: Seonkyeong Yang, et al.
Published: (2022-06-01) -
Proposed mechanisms of action of herbal drugs and their biologically active constituents in the treatment of coughs: an overview
by: Jana Pourova, et al.
Published: (2023-10-01) -
Phytopharmaceutical practices of traditional health practitioners in Burkina Faso: a cross-sectional study
by: Kampadilemba Ouoba, et al.
Published: (2023-06-01)